<DOC>
	<DOCNO>NCT00778297</DOCNO>
	<brief_summary>This single blind , reference drug control , one center viral immunogenicity tolerability study FluvalAB FL-K-004 Trivalent Influenza Vaccine 6 μg HA/strain/dos antigen content ass immunogenicity tolerability . The aim study assess immunogenicity tolerability FluvalAB FL-K-004 trivalent influenza vaccine 6 μg HA/strain/dos antigen content ( study drug ) age group 18-60 year 60 year , objective verify efficacy tolerability study drug accord CPMP/BWP/214/96 : `` Note Guidance Harmonization Requirements Influenza Vaccines '' , 12 March 1997 .</brief_summary>
	<brief_title>Immunogenicity Tolerability Study FluvalAB FL-K-004 Trivalent Influenza Vaccine</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Adult volunteer good health age 18 year , sex ; Full contractual capacity participant ; Are good health ( determine vital sign medical history ) ; Negative urine serum pregnancy test female childbearing potential ; Are able understand comply plan study procedure ; Signed informed consent prior initiation study procedure ; Absence existence exclusion criterion . Known allergy egg component vaccine ; History GuillainBarré syndrome ; Pregnancy breast feed positive pregnancy test prior vaccination ; Immunosuppressive therapy precede 36 month ; Active neoplasm ( i.e . require form antineoplastic therapy ) ; Concomitant corticosteroid therapy , include inhaled corticosteroid ; Psychiatric illness and/or concomitant psychiatric drug therapy ; Immunoglobulin ( similar blood product ) therapy within 3 month prior vaccination ; Vaccine therapy within 4 week prior study ; Influenza vaccination within 6 month prior study ; Chronic illness , opinion investigator , may interfere evaluation immune response ; Documented HIV , HBV HCV infection ; Acute febrile respiratory illness within one week prior vaccination ; Experimental drug therapy within 1 month prior vaccination ; Alcohol drug abuse .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>prevention</keyword>
	<keyword>influenza</keyword>
	<keyword>infection</keyword>
	<keyword>vaccine</keyword>
	<keyword>Influenza vaccine</keyword>
	<keyword>Influenza human</keyword>
</DOC>